Ukraine has urged organisers of the Venice Biennale to reconsider Russia’s participation in the prestigious art exhibition, arguing that it must not become “a stage for whitewashing… war crimes.” Biennale organisers said last week that Russia would be allowed to take part in the event, held from 9 May until 22 November, triggering widespread criticism, including from Italy’s culture ministry, whic...
Ukraine has urged organisers of the Venice Biennale to reconsider Russia’s participation in the prestigious art exhibition, arguing that it must not become “a stage for whitewashing… war crimes.” Biennale organisers said last week that Russia would be allowed to take part in the event, held from 9 May until 22 November, triggering widespread criticism, including from Italy’s culture ministry, which said it opposed the decision. Days after Russia’s full-scale invasion of Ukraine in February 2022, the biennale, one of Italy’s most important cultural institutions, condemned the aggression and banned access to that year’s event for anyone linked to the Kremlin. Although it never formally barred the country from participating, Russia was absent in 2022 and 2024. “The Venice Biennale is one of the world’s most authoritative art platforms, and it must not become a stage for whitewashing the war crimes that Russia commits daily against the Ukrainian people and our cultural heritage,” Ukraine’s foreign minister, Andriy Sybiha, and the culture minister, Tetyana Berezhna, said in a statement on Sunday. “We call on the organisers of the Venice Biennale to reconsider their decision to allow the Russian Federation to return and to maintain the principled position demonstrated in 2022-2024.” They said they found the biennale’s change of position “incomprehensible”, given its previous condemnation of the invasion. Russia “has waged a systematic war against Ukrainian culture, identity, and historical memory”, the statement added, while killing 346 artists and 132 Ukrainian and foreign journalists, destroying or damaging more than 1,700 cultural heritage sites and stealing over 35,000 museum relics. The biennale said in its statement last week that the exhibition was “an open institution” that “rejects any form of exclusion or censorship of art”. On Friday, a group of cross-party MEPs published a letter condemning Russia’s inclusion as “unacceptable”. “Such a choice risks lending leg...
China will enact a law to combat cross-border corruption this year, according to the top legislature’s work report released on Monday – a move aimed at preventing corruption by companies overseas, which some experts said could shield them from foreign “long-arm jurisdiction” The work report, submitted by the National People’s Congress (NPC) Standing Committee to the fourth session of the 14th NPC ...
China will enact a law to combat cross-border corruption this year, according to the top legislature’s work report released on Monday – a move aimed at preventing corruption by companies overseas, which some experts said could shield them from foreign “long-arm jurisdiction” The work report, submitted by the National People’s Congress (NPC) Standing Committee to the fourth session of the 14th NPC for deliberation, provided no details or specific timeline for the legislation. The law is expected to step up China’s anti-corruption work overseas, targeting fugitives and illicit assets abroad, as well as corruption involving overseas businesses. It will be drafted by the Central Commission for Discipline Inspection, China’s highest political disciplinary and anti-corruption agency. Advertisement Chinese authorities first officially stated their goal of enacting the law in 2023, when it was listed in the NPC Standing Committee’s legislative plan as an item for which conditions were deemed “relatively mature”. In 2024, the third plenary session of the Communist Party’s Central Committee also called for the legislation. Advertisement
Some local governments in China have rushed to support the adoption of OpenClaw, the artificial intelligence agent sweeping the country, even as warnings about privacy and security risks linger in the background. In Shenzhen, China’s southern tech hub, the AI and robotics agency of Longgang district published a draft on Saturday proposing sweeping measures, including subsidies of up to 2 million y...
Some local governments in China have rushed to support the adoption of OpenClaw, the artificial intelligence agent sweeping the country, even as warnings about privacy and security risks linger in the background. In Shenzhen, China’s southern tech hub, the AI and robotics agency of Longgang district published a draft on Saturday proposing sweeping measures, including subsidies of up to 2 million yuan (US$290,000) for approved projects. The initiative came a day after nearly a thousand people queued outside Chinese tech giant Tencent Holdings’ Shenzhen headquarters to have OpenClaw installed for free by company engineers. Chinese social media platforms have also been flooded with posts offering paid services to install the software. Advertisement The hi-tech district of Wuxi in the eastern Jiangsu province announced a similar policy on Monday, offering subsidies of between 1 million yuan and 5 million yuan to encourage innovative industrial applications of OpenClaw such as quality inspection and equipment maintenance solutions. The moves come after the National Vulnerability DataBase (NVDB), a cybersecurity information centre under the Ministry of Industry and Information Technology , cautioned that improper configuration of the software would expose users to high-level security risks, leading to issues such as cyberattacks or privacy leaks. People queue outside Tencent Holdings’ Shenzhen headquarters to have OpenClaw installed. Photo: Handout The warning came amid a nationwide rush to embrace OpenClaw, a trend dubbed “raise the lobster” for its promise of performing tasks on users’ behalf.
Can income investors get in on the coming SpaceX IPO before the stock goes public (and ideally without overpaying?) Let's find out. No announcement of an IPO has been made, but SpaceX's recent acquisition of Starlink and Musk's xAI firm signal that an offering is in the pipeline. Even though the company still feels relatively new, SpaceX successfully launched its first rocket 18 years ago. Since t...
Can income investors get in on the coming SpaceX IPO before the stock goes public (and ideally without overpaying?) Let's find out. No announcement of an IPO has been made, but SpaceX's recent acquisition of Starlink and Musk's xAI firm signal that an offering is in the pipeline. Even though the company still feels relatively new, SpaceX successfully launched its first rocket 18 years ago. Since then, it has reportedly earned roughly $20 billion in government contracts, with Morningstar recently reporting that it posted about $8 billion of profits on $15 billion of revenue in 2025. If those numbers stand up--and there's no way for us to confirm them--that's a profit margin above 50%. The company's success with Starlink will likely help keep its margins high. Which brings us back to the question I just asked: Can we get in, say, now, before the stock trades publicly? The answer is yes, there are a couple of routes. Both run through funds--either an ETF or a closed-end fund (CEF)--with exposure to the company. Here are two options, with a third (my preferred choice) at the end. Option 1: The ETF Play The ERShares Private-Public Crossover ETF (XOVR) holds SpaceX indirectly, through a "special purpose vehicle"--a type of private fund focused on private securities. XOVR then balances its SpaceX exposure with public tech firms like NVIDIA (NVDA), Meta Platforms (META) and Palantir Technologies (PLTR). There's also a dash of healthcare in its top-10 holdings, with medical-device maker ResMed (RMD), and finance, in the form of Interactive Brokers Group (IBKR), a trading-services firm. That seems like a pretty good mix from a risk-management perspective, right? Unfortunately, it has still led to a pretty rough long-term performance: XOVR Lags the Tech Sector and the NASDAQ As you can see above, since the inception of XOVR (in purple), the fund has returned less than a third of the return of the State Street Technology Select Sector SPDR ETF (XLK), in blue and a good benchmar...
Investing.com -- Barclays lowered its price target on Oracle to $230 from $310 in a note on Monday, warning that accelerating AI-related growth will also bring near-term margin pressure. Analyst Raimo Lenschow told investors that Oracle’s fiscal third quarter should show “a meaningful AI-driven revenue acceleration,” but noted that the same ramp “will likely also pressure margins from upfront cost...
Investing.com -- Barclays lowered its price target on Oracle to $230 from $310 in a note on Monday, warning that accelerating AI-related growth will also bring near-term margin pressure. Analyst Raimo Lenschow told investors that Oracle’s fiscal third quarter should show “a meaningful AI-driven revenue acceleration,” but noted that the same ramp “will likely also pressure margins from upfront costs/timing.” Lenschow believes AI revenue should be “a little better compared to consensus” as more capacity came online in Q3, and that foreign-exchange trends were “more favorable than guided.” But he cautioned that gross margins and EPS face headwinds as “upfront investments and lease expense timing for the additional huge capacity ramps in H2 CY26 will create negative timing effects.” Barclays expects this to leave investors split, writing that “bulls (including us) will focus on the ongoing growing momentum for the company, while bears have at least the margins to pick on.” The firm added that Q3 “will not be a conclusive quarter either way.” Lenschow also argued that Oracle’s AI infrastructure build-out is misunderstood, saying investors “need to rethink how they are looking at ORCL and other AI infrastructure players” because major deals are effectively“a series of AI data center agreements requiring a project-finance lens. He said this structure gives Oracle flexibility to adjust capacity or timelines without committing unnecessary capital. While sentiment toward AI infrastructure peers has weakened, Barclays maintained an Overweight rating on Oracle, noting a “compelling risk/reward” as Oracle evolves into “a very different company in the future.” Related articles Oracle stock price target cut at Barclays on margin pressure JPMorgan outlines ten strategic themes that could shape the outlook for 2026 As Claude disrupts stock market, Anthropic researcher warns ’world is in peril’
Key Highlights Microsoft unveiled Copilot Cowork, leveraging Anthropic’s Claude Cowork platform, designed for Microsoft 365 business customers The AI agent automates workflows including presentation creation, Excel data manipulation, and calendar coordination with minimal user intervention MSFT shares have declined 15% year-to-date, with an additional 9% drop in February after Anthropic’s Claude C...
Key Highlights Microsoft unveiled Copilot Cowork, leveraging Anthropic’s Claude Cowork platform, designed for Microsoft 365 business customers The AI agent automates workflows including presentation creation, Excel data manipulation, and calendar coordination with minimal user intervention MSFT shares have declined 15% year-to-date, with an additional 9% drop in February after Anthropic’s Claude Cowork announcement The tech giant is integrating Claude Sonnet models into M365 Copilot, diversifying away from exclusive OpenAI GPT dependency Microsoft 365 Copilot subscription seats surged 160% year-over-year during the latest reporting period On Monday, Microsoft revealed Copilot Cowork, an innovative AI agent solution developed through a partnership with Anthropic. This release integrates Claude Cowork’s self-sufficient features straight into the Microsoft 365 platform. Microsoft Corporation, MSFT The intelligent assistant can generate slide decks, fill spreadsheet cells, and coordinate with team members for scheduling — requiring only basic direction from users. The feature remains in beta testing, with broader availability planned for select enterprise customers within weeks. Microsoft emphasized its security infrastructure as a differentiator. While Claude Cowork functions locally on individual machines, Copilot Cowork runs exclusively through cloud infrastructure. “We work only in a cloud environment and we work only on behalf of the user. So you know exactly what information it has access to,” said Jared Spataro, who leads Microsoft’s AI-at-Work efforts. The release comes at a strategic moment. Anthropic’s initial Claude Cowork announcement on January 30 triggered widespread concern across technology equities. Companies like Salesforce (CRM), ServiceNow (NOW), Intuit (INTU), and Thomson Reuters (TRI) experienced significant declines. Microsoft wasn’t spared either. The company’s shares tumbled almost 9% during February in response to the Cowork announcement. Year-...
OpenAI is delaying the launch of “adult mode” for ChatGPT after admitting it had more pressing priorities than introducing erotica on its signature artificial intelligence product. The startup’s chief executive, Sam Altman, had announced last year that OpenAI would allow adult content as it rolled out age checking. However, the company has now said the plan has been delayed in favour of more immed...
OpenAI is delaying the launch of “adult mode” for ChatGPT after admitting it had more pressing priorities than introducing erotica on its signature artificial intelligence product. The startup’s chief executive, Sam Altman, had announced last year that OpenAI would allow adult content as it rolled out age checking. However, the company has now said the plan has been delayed in favour of more immediate requirements such as improving ChatGPT’s performance. “We’re pushing out the launch of adult mode so we can focus on work that is a higher priority for more users right now, including gains in intelligence, personality improvements, personalisation, and making the experience more proactive,” said OpenAI, which has more than 900 million users of ChatGPT. “We still believe in the principle of treating adults like adults, but getting the experience right will take more time.” Since he announced plans last October to relax restrictions on ChatGPT, Altman has declared a “code red” to improve the chatbot amid concerted competition from rivals led by Google and Anthropic. In the meantime, OpenAI is rolling out age prediction tools that determine whether a user is under 18. If a user is underage, extra safety settings kick in, reducing exposure to graphic violence and sexual role play. In the UK, if ChatGPT produces images that are deemed pornographic under the Online Safety Act, OpenAI would need to shield that content from underage users with strict age checking. Separately, one of the most senior managers at OpenAI has resigned over the startup’s US deal with the Pentagon. Caitlin Kalinowski, the head of hardware within OpenAI’s robotics division, said she was concerned about mass surveillance of US citizens and AI-guided machines carrying out autonomous killing. “This wasn’t an easy call,” Kalinowski wrote in a post on X. “AI has an important role in national security. But surveillance of Americans without judicial oversight and lethal autonomy without human authorization ...
Shares of Hims & Hers Health ( HIMS ) surged more than 45% on Monday morning, a move that is likely to ripple across a broad range of exchange traded funds that hold the telehealth provider. The rally follows news that Hims & Hers struck an agreement with Novo Nordisk ( NVO ) to offer the pharmaceutical giant’s GLP-1 weight-loss medications while discontinuing the marketing of its compounded GLP-1...
Shares of Hims & Hers Health ( HIMS ) surged more than 45% on Monday morning, a move that is likely to ripple across a broad range of exchange traded funds that hold the telehealth provider. The rally follows news that Hims & Hers struck an agreement with Novo Nordisk ( NVO ) to offer the pharmaceutical giant’s GLP-1 weight-loss medications while discontinuing the marketing of its compounded GLP-1 products. Because HIMS is widely held across the ETF landscape, the sharp jump in the stock could provide a performance boost for numerous funds with meaningful exposure. In total, 113 exchange traded funds collectively own nearly 45M shares of Hims & Hers. With the stock’s surge, ETFs with the largest allocations to HIMS may see the most immediate impact, underscoring how single-stock momentum can quickly flow through diversified portfolios. Below are the 10 ETFs with the largest allocations to HIMS. Roundhill Meme Stock ETF ( MEME ), 8.71% allocation. Global X Telemedicine & Digital Health ETF Registered (EDOC), 5.74% allocation. Fidelity Digital Health ETF ( FDHT ), 2.67% allocation. Kurv High Income ETF ( KYLD ), 2.01% allocation. Global X Telemedicine & Digital Health ETF Registered ( HEAL ), 1.78% allocation. Amplify Weight Loss Drug & Treatment ETF ( THNR ), 1.55% allocation. First Trust Nasdaq Lux Digital Health Solutions ETF ( EKG ), 1.47% allocation. Amplify Online Retail ETF ( IBUY ), 0.97% allocation. SPDR S&P Health Care Services ETF ( XHS ), 0.83% allocation. Principal U.S. Small-Cap ETF ( PSC ), 0.69% allocation. More on markets Dividend stocks build momentum as Middle East tensions push oil above $100/bbl RBC Capital Markets holds S&P 500 target, says Iran conflict too early to shift view How high can oil rise this year? Prediction markets price a possible $180 peak Strait of Hormuz closure looks like a coin flip as traders forecast essentially 50-50 chance Apollo warns Strait of Hormuz disruption could rattle global energy supply
Michael Vi/iStock Editorial via Getty Images Topline results from a phase 1 study of AbbVie's ( ABBV ) amylin analogue ABBV-295 for obesity showed the candidate led to significant weight loss at weekly, bi-weekly, and monthly dosing schedules. At week 12 with weekly dosing, average weight loss ranged from 7.75% to -9.79%. At week 13 with every other week dosing followed by monthly dosing after wee...
Michael Vi/iStock Editorial via Getty Images Topline results from a phase 1 study of AbbVie's ( ABBV ) amylin analogue ABBV-295 for obesity showed the candidate led to significant weight loss at weekly, bi-weekly, and monthly dosing schedules. At week 12 with weekly dosing, average weight loss ranged from 7.75% to -9.79%. At week 13 with every other week dosing followed by monthly dosing after week five, average weight loss ranged from -7.86% to -9.73%. Doses examined ranged from 2 mg-14 mg. AbbVie noted that ABBV-295 was well tolerated at all dosage strengths with no serious adverse events reported. The most common side effects reported were gastrointestinal in nature and mild. ABBV-295 an agonist that activates amylin and calcitonin receptors, a different mechanism of action from GLP-1s that are currently dominating the obesity therapy market. More on AbbVie AbbVie: Stabilizes Near $233 While Testing Resistance AbbVie Inc. (ABBV) Presents at TD Cowen 46th Annual Health Care Conference Transcript Health Care Q4 Dividend Roundup: Merck Offers Thicker Dividend Cushion Than AbbVie FDA plans to relax testing rules to encourage biosimilar drugs: report Pharma giants pressed by Senate Democrats over Trump pricing deals
French President Emmanuel Macron seeks to launch a joint maritime mission to escort container ships in an effort to reopen the Strait of Hormuz once the initial phase of the war has calmed down. The Strait of Hormuz has been effectively closed since the start of the Iran war. France plans to set up a “purely defensive” mission with both European and non-European nations to “escort container ships ...
French President Emmanuel Macron seeks to launch a joint maritime mission to escort container ships in an effort to reopen the Strait of Hormuz once the initial phase of the war has calmed down. The Strait of Hormuz has been effectively closed since the start of the Iran war. France plans to set up a “purely defensive” mission with both European and non-European nations to “escort container ships and tankers,” Macron told reporters from the Paphos airbase in Cyprus. Macron said the idea is to “gradually reopen the Strait of Hormuz” after the “hottest” phase of the conflict.
Key Points Rice Hall James purchased 574,877 shares of QuidelOrtho stock in the fourth quarter. The quarter-end position value grew by $16.2 million, reflecting both additional shares and price changes. The quarter-end stake was 833,791 shares, valued at $23.8 million. The position represented 1.3% of fund assets, as reported in 13F, which places it outside the fund's top five holdings. 10 stocks ...
Key Points Rice Hall James purchased 574,877 shares of QuidelOrtho stock in the fourth quarter. The quarter-end position value grew by $16.2 million, reflecting both additional shares and price changes. The quarter-end stake was 833,791 shares, valued at $23.8 million. The position represented 1.3% of fund assets, as reported in 13F, which places it outside the fund's top five holdings. 10 stocks we like better than QuidelOrtho › On Feb. 13, 2026, Rice Hall James & Associates, LLC disclosed a buy of QuidelOrtho (NASDAQ:QDEL) in the fourth quarter. What happened An SEC filing dated Feb. 13, 2026, shows Rice Hall James & Associates, LLC bought 574,877 shares of QuidelOrtho during the fourth quarter. The quarter-end value of the position increased by $16.2 million, reflecting both trading activity and stock price movements. What else to know The additional shares increased the QuidelOrtho stake to 1.3% of the fund's 13F reportable assets under management (AUM). Top holdings after the filing: NASDAQ: LGND: $52.8 million (2.9% of AUM) NYSE: ARLO: $50.0 million (2.7% of AUM) NASDAQ: FOLD: $49.9 million (2.7% of AUM) NYSE: FN: $48.4 million (2.7% of AUM) NASDAQ: ESTA: $47.4 million (2.6% of AUM) As of Feb. 13, 2026, shares were priced at $23.58, down 43.4% over the past year and trailing the S&P 500 by 55.2 percentage points. Company overview Metric Value Revenue (TTM) $2.7 billion Net income (TTM) ($1.1 billion) Market capitalization $1.6 billion Price (as of market close February 13, 2026) $23.58 Company snapshot Develops and manufactures diagnostic testing technologies spanning labs, transfusion medicine, point-of-care, and molecular diagnostics, with a broad portfolio of clinical chemistry, immunoassay, and blood screening products. Generates revenue through direct sales and distributor channels, offering instruments, consumables, and diagnostic tests for both professional and over-the-counter use worldwide. Serves hospitals, clinical and reference laboratories, physic...
Sundry Photography U.S. Bancorp's ( USB ) registered investment advisor business launched a new set of offerings designed for individuals who are new to investing or beginning to build wealth, the company said on Monday. The move underscores traditional banks' mobilization to compete with fintechs and to convince investors that they have a broader scope to handle retail investors' wealth. The new ...
Sundry Photography U.S. Bancorp's ( USB ) registered investment advisor business launched a new set of offerings designed for individuals who are new to investing or beginning to build wealth, the company said on Monday. The move underscores traditional banks' mobilization to compete with fintechs and to convince investors that they have a broader scope to handle retail investors' wealth. The new suite of offerings includes a new team-based investment advisory service for investors with at least $25,000, an enhanced self-directed brokerage service with no minimum investment, and a next-generation investment platform that integrates banking (through U.S. Bank) and investing. " With this suite of capabilities, we’re meeting people where they are — independently, with an advisor, or a blend of both," said Scott Ford, president of Wealth Management at U.S. Bank ( USB ) . "By combining transparent, low‑cost tools with our research and expertise, we’re helping customers link their investments to life goals and take informed steps at every stage." The company named Ryan K. Nelson as president of Emerging Affluent Wealth Management to head the introduction of the services. Most recently, he served as U.S. Bank's East regional executive for Private Wealth Management. The three main pieces of the services include Wealth Connect, a team-based, fee-based advisory service for those with $25,000 or more to invest; Self-Directed Investing; and a Next-Generation Investing platform. U.S. Bancorp ( USB ) stock slipped 1.7% in premarket trading, amid weakness in the broader equity markets. More on U.S. Bancorp U.S. Bancorp H PFD Vs. Owning One Of The 4 Fixed-Rate PFDs U.S. Bancorp: Dividend Value Stock In Buy Range U.S. Bancorp (USB) Q4 2025 Earnings Call Transcript U.S. Bancorp raised to Buy from Hold at Truist Securities U.S. Bancorp names Gunjan Kedia to be chairman in April
Banks led by Bank of America Corp. have launched a $2.75 billion leveraged loan to help fund Nexstar Media Group Inc. ’s pending acquisition of rival TV-station owner Tegna Inc. The loan is being pitched at a margin of as much as three percentage points above benchmark and a discounted price of 99 cents on the dollar, according to a person familiar with the matter. A lender call will be held at 10...
Banks led by Bank of America Corp. have launched a $2.75 billion leveraged loan to help fund Nexstar Media Group Inc. ’s pending acquisition of rival TV-station owner Tegna Inc. The loan is being pitched at a margin of as much as three percentage points above benchmark and a discounted price of 99 cents on the dollar, according to a person familiar with the matter. A lender call will be held at 10 a.m. New York time with commitments due March 18, said the person, who asked not to be identified as they’re not authorized to speak publicly. Lenders had committed to provide as much as $5.73 billion of debt financing to support the acquisition, refinance some Tegna obligations and related transactions, according to a Nexstar filing . The offering will test investor appetite as the leveraged loan market grapples with AI-driven disruption fears and an escalating conflict in the Middle East. Nexstar’s proposed purchase of Tegna was announced in August , and without divestitures would create a company whose stations would reach 80% of US TV households. The deal requires US government approval, and the companies have targeted to close the combination by the second half of 2026. It’s among several deals that are set to alter America’s media landscape. Paramount Skydance Corp. — itself the creation of a recent combination — last month agreed to pay $111 billion for Warner Bros. Discovery Inc.
Key Points SoFi's customer growth has been driving phenomenal financial results. Roku aims to dominate its niche in the streaming industry and expand its footprint in new international markets. 10 stocks we like better than SoFi Technologies › Cathie Wood, founder and CEO of investment management firm Ark Invest, can be a somewhat polarizing figure. Some believe her focus on companies with strong ...
Key Points SoFi's customer growth has been driving phenomenal financial results. Roku aims to dominate its niche in the streaming industry and expand its footprint in new international markets. 10 stocks we like better than SoFi Technologies › Cathie Wood, founder and CEO of investment management firm Ark Invest, can be a somewhat polarizing figure. Some believe her focus on companies with strong innovative qualities gives her actively managed exchange-traded funds (ETFs) unique strengths. And indeed, those Ark ETFs did outperform the broader market during the challenging early pandemic years. But as a Morningstar analysis pointed out early last year, over the longer term, the performance of Ark ETFs as a group has been terrible. Regardless, one thing is for sure: At least some of the dozens of stocks in Wood's various innovation-centric portfolios look attractive right now. Two that I think will perform well over the next decade are SoFi Technologies (NASDAQ: SOFI) and Roku (NASDAQ: ROKU). Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » 1. SoFi Technologies SoFi Technologies' stock has been on fire lately. Propelled by its excellent financial results, its share price has increased by 85% so far this year. In the second quarter, SoFi's revenue rose by 44% year over year to $858 million. Importantly, the company's recurring fee-based revenue increased by 72% to $378 million, which was approximately 44% of its total sales. SoFi's membership and products per member metrics continued to move in the right direction, too, and its net income for the period was up 459% to $97.3 million. The fintech company, which in its early years focused solely on student loan refinancing, has transformed itself into a full-fledged financial services provider with a diversified lineup of products, including investment services and various types of loans. Furthermore, SoFi is an entirely online bank, so ...
Investors looking for ways to capitalize on the rapidly growing artificial intelligence (AI) industry may want to pay attention to the portfolio moves of some of the top names on Wall Street. Take David Tepper, the founder and president of Appaloosa Management, a hedge fund that has delivered excellent returns for decades. In the fourth quarter, the fund made some noteworthy sales and purchases. F...
Investors looking for ways to capitalize on the rapidly growing artificial intelligence (AI) industry may want to pay attention to the portfolio moves of some of the top names on Wall Street. Take David Tepper, the founder and president of Appaloosa Management, a hedge fund that has delivered excellent returns for decades. In the fourth quarter, the fund made some noteworthy sales and purchases. For instance, it trimmed its stake in AI leader Nvidia by about 10.5% while at the same time boosting its stake by 28.8% in another leading AI company: Alphabet (GOOG 0.83%) (GOOGL 0.86%). Here's why it could be a good idea to, at the very least, follow Tepper's lead and invest in the Google parent. Alphabet has been on fire Over the past five years, Alphabet's shares have climbed by 190%, compared to a 75.7% gain for the S&P 500. That strong outperformance is all the more impressive considering that the tech leader has faced some headwinds. When OpenAI launched ChatGPT, some investors feared that AI chatbots would cut into the overall use of Alphabet's Google search engine. Further, Alphabet was facing antitrust lawsuits that could have resulted in it being compelled to spin off key parts of its business. Yet it has navigated both obstacles. AI turned out to be a strength, not a weakness, for Alphabet. It launched its own AI chatbot and added an AI mode and AI overviews to Google search. These efforts have helped it grow user engagement and strengthen the company's advertising business. Further, while Alphabet was found to have violated antitrust laws, it emerged from those court cases with relatively minimal penalties. Most importantly, it avoided the worst-case scenario of being ordered to divest its Chrome browser. Alphabet stock's ability to crush the market despite all these obstacles speaks volumes about the business. Expand NASDAQ : GOOGL Alphabet Today's Change ( -0.86 %) $ -2.57 Current Price $ 295.74 Key Data Points Market Cap $3.6T Day's Range $ 294.09 - $ 296.80...